Samuel J Klempner

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi Safety of cupping during bevacizumab therapy
    Samuel J Klempner
    Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Altern Complement Med 19:729-31. 2013
  2. pmc Complementary and alternative medicines in prostate cancer: from bench to bedside?
    Samuel J Klempner
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
    Oncologist 17:830-7. 2012

Detail Information

Publications2

  1. doi Safety of cupping during bevacizumab therapy
    Samuel J Klempner
    Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Altern Complement Med 19:729-31. 2013
    ..There are no data on the safety of cupping in patients being treated with bevacizumab...
  2. pmc Complementary and alternative medicines in prostate cancer: from bench to bedside?
    Samuel J Klempner
    Division of Hematology Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
    Oncologist 17:830-7. 2012
    ..The purpose of this review is to more rigorously evaluate CAM therapy in prostate cancer and educate oncologists and patients. This review focuses on examples from the general classes of agents in common use...